“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444.


Source: Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017
Journal Issue: February

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444.. Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051.
Source: Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019
Year: 2020


“Dead space: the physiology of wasted ventilation.” H. Thomas Robertson. Eur Respir J 2015; 45: 1704–1716.
Source: Eur Respir J 2015; 46: 1226
Year: 2015


“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057.
Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018
Year: 2018


“Exercise pulmonary haemodynamics: a test in search of purpose.” J. Gerry Coghlan and Harm Jan Bogaard. Eur Respir J 2016; 47: 1315–1317.
Source: Eur Respir J 2016; 48: 285
Year: 2016


“Health consequences associated with frequent wheezing in adolescents without asthma diagnosis.” K. Yeatts, K. Johnston Davis, D. Peden and C. Shy. Eur Respir J 2003; 22: 781–786.
Source: Eur Respir J 2015; 46: 1532
Year: 2015


“Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing.” Denis E. O'Donnell, Amany F. Elbehairy, Azmy Faisal, Katherine A. Webb, J. Alberto Neder and Donald A. Mahler. Eur Respir Rev 2016; 25: 333–347.
Source: Eur Respir Rev 2016; 25: 513
Year: 2016



“Contact investigation for tuberculosis: a systematic review and meta-analysis.” Gregory J. Fox, Simone E. Barry, Warwick J. Britton and Guy B. Marks. Eur Respir J 2013; 41: 140–156.
Source: Eur Respir J 2015; 46: 578
Year: 2015


“Alveolar macrophages carbon load: a marker of exposure?” Chinedu Nwokoro, Rossa Brugha and Jonathan Grigg. Eur Respir J 2013; 41: 763.
Source: Eur Respir J 2013; 42: 295
Year: 2013


“Tidal flow variability measured by impedance pneumography relates to childhood asthma risk.” Ville-Pekka Seppä, Anna S. Pelkonen, Anne Kotaniemi-Syrjänen, Jari Viik, Mika J. Mäkelä and L. Pekka Malmberg. Eur Respir J 2016; 47: 1687–1696.
Source: Eur Respir J 2016; 48: 285
Year: 2016


“Lung function race, ethnicity: a conundrum.” Philip H. Quanjer. Eur Respir J 2013; 41: 1249–1251.
Source: Eur Respir J 2013; 42: 1162
Year: 2013


“Adult-onset asthma: is it really different?” Selma B. de Nijs, Lisette N. Venekamp and Elisabeth H. Bel. Eur Respir Rev 2013; 22: 44–52.
Source: Eur Respir Rev 2013; 22: 193
Year: 2013


“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647.
Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019
Year: 2020



“Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD.” Ciro Casanova and Bartolome R. Celli. Eur Respir J 2014; 43: 951–953.
Source: Eur Respir J 2014; 43: 1825
Year: 2014


“Lung cancer survival in Norway, 1997–2011: from nihilism to optimism.” Yngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, Kristian Bartnes and Bjørn Møller. Eur Respir J 2016; 47: 275–287.
Source: Eur Respir J 2016; 47: 1297
Year: 2016


“Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.” Stephen Y. Chan and Lewis J. Rubin. Eur Respir Rev 2017; 26: 170094.
Source: Eur Respir Rev, 27 (147) 175094; 10.1183/16000617.5094-2017
Year: 2018


“Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.” Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. Eur Respir Rev 2017; 26: 170050.
Source: Eur Respir Rev, 27 (148) 175050; 10.1183/16000617.5050-2017
Year: 2018


“Umeclidinium in patients with COPD: a randomised, placebo-controlled study.” Roopa Trivedi, Nathalie Richard, Rashmi Mehta and Alison Church. Eur Respir J 2014; 43: 72–81.
Source: Eur Respir J 2014; 44: 555
Year: 2014


“Towards a total ban on links with the tobacco industry: new rules for the ERS.” Klaus F. Rabe, Christina Gratziou, Brian Ward and Florence Berteletti. Eur Respir J 2012; 40: 809–810.
Source: Eur Respir J 2012; 40: 1307
Year: 2012


“Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27.},
Source: Eur Respir J 2012; 40: 800
Year: 2012


“Do bacteria have a role in asthma development?” J. Armann and E. von Mutius. Eur Respir J 2010; 36: 469–471.
Source: Eur Respir J, 54 (1) 1050414; 10.1183/13993003.50414-2010
Year: 2019